2014
DOI: 10.1155/2014/718432
|View full text |Cite
|
Sign up to set email alerts
|

Reducing the Foreign Body Reaction by Surface Modification with Collagen/Hyaluronic Acid Multilayered Films

Abstract: Biological response against foreign implants often leads to encapsulation, possibly resulting in malfunction of implants devices. The aim of this study was to reduce the foreign body reaction by surface modification of biomaterials through layer-by-layer deposition of type I collagen (COL)/hyaluronic acid (HA) multilayer films. Polydimethylsiloxane (PDMS) samples were coated with alternative COL and HA layers with different layers. We found that the in vitro adhesion, proliferation, and activation of macrophag… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(15 citation statements)
references
References 44 publications
0
12
0
Order By: Relevance
“…Another application, especially of multilayer‐assembled or ‐coated microcapsules/‐beads, represents the transport of drugs, since the association with specific binding molecules such as GAGs can prevent drugs from rapid release and degradation, and act as a target‐oriented delivery system (De Koker et al, ). Multilayer coatings made of GAGs showed in vitro and in vivo macrophage activation, and decrease of capsule formation in vivo , which is related to their anti‐inflammatory properties (Hsieh et al, ; Zhou et al, 2016).…”
Section: Applications Of Glycosaminoglycans In 2d and 3d Systems In Tmentioning
confidence: 99%
See 1 more Smart Citation
“…Another application, especially of multilayer‐assembled or ‐coated microcapsules/‐beads, represents the transport of drugs, since the association with specific binding molecules such as GAGs can prevent drugs from rapid release and degradation, and act as a target‐oriented delivery system (De Koker et al, ). Multilayer coatings made of GAGs showed in vitro and in vivo macrophage activation, and decrease of capsule formation in vivo , which is related to their anti‐inflammatory properties (Hsieh et al, ; Zhou et al, 2016).…”
Section: Applications Of Glycosaminoglycans In 2d and 3d Systems In Tmentioning
confidence: 99%
“…Porous mesh Artificial ECM, Cartilage regeneration Ji et al, 2006;Zhong et al, 2007) Crosslinked Collagen-HS matrices + bFGF Porous scaffold Enhancement of angiogenesis/ regeneration (Pieper et al, 2002) (Xu et al, 2011) Thiolated Hep-PEG Nanoparticles (Nanogels) Drug delivery, cancer therapy (Bae et al, 2008) degradation, and act as a target-oriented delivery system (De Koker et al, 2012). Multilayer coatings made of GAGs showed in vitro and in vivo macrophage activation, and decrease of capsule formation in vivo, which is related to their anti-inflammatory properties (Hsieh et al, 2014;Zhou et al, 2016). For biomedical applications, a certain durability of the coating plays a crucial role.…”
Section: Porous Scaffoldmentioning
confidence: 99%
“…The cause of capsular contracture might be bacterial infection, implant shell rupture, and hematoma, but nevertheless interaction between implant and the surrounding injured tissue. Implant surface modification of biomaterials to reduce the capsular thickness is proved, which may be due to down regulation of macrophage adhesion and activation [12]. However, possible mechanism is still unknown.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast to synthetics, organic biomaterials and hydrogels composed of ECM components, collagen (Suri and Schmidt, 2010 ), hyaluronic acid (Hsieh et al, 2014 ), fibrin (Ahmed et al, 2008 ), and alginate (Banerjee et al, 2009 ) represent a better choice, because they exhibit superior biocompatibility (Kim et al, 2007 ; Fujihara et al, 2010 ) and have been shown to effectively regulate the macrophage adhesion and activation in vitro , as well as the capsule formation in vivo (Hsieh et al, 2014 ). Previous studies have found that allogeneic human ECM proteins are well tolerated by the host and do not appear to elicit either a cell mediated or humoral immune response (Allaire et al, 1994 , 1997 ).…”
Section: Possible Strategies To Reduce Fbrmentioning
confidence: 99%